Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Profit before tax | 52.73 | 56.01 | 16.65 | 11.95 | 91.63 |
| Net cashflow-operating activity | 118.01 | 19.81 | 15.63 | -13.62 | 64.76 |
| Net cash used in investing activity | -24.10 | -20.20 | -7.55 | -7.69 | -177.34 |
| Netcash used in fin. activity | -92.29 | 0.96 | -9.98 | 20.74 | -51.83 |
| Net inc/dec in cash and equivlnt | 1.63 | 0.56 | -1.90 | -0.57 | -164.41 |
| Cash and equivalnt begin of year | 1.12 | 0.55 | 2.45 | 3.13 | 167.54 |
| Cash and equivalnt end of year | 2.75 | 1.12 | 0.55 | 2.56 | 3.13 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis